Broker says A2 Milk share price can keep rising

A2 Milk shares have been tipped to keep rising from here…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The A2 Milk Company Ltd (ASX: A2M) share price has been a strong performer this week.

Over the first two trading sessions, the infant formula company's shares have stormed 16% higher.

This has been driven by the release of a stronger than expected full year result on Monday.

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements

Image source: Getty Images

Can the A2 Milk share price keep rising?

The good news for shareholders is that one leading broker still sees scope for the A2 Milk share price to rise further from here.

According to a note out of Bell Potter, its analysts have upgraded the company's shares to a buy rating and lifted the price target on them by a third to $6.35.

Based on the current A2 Milk share price of $5.73, this implies potential upside of almost 11% over the next 12 months.

What did the broker say?

Bell Potter was impressed with A2 Milk's performance in FY 2022, noting that its result came in ahead of expectations.

The broker was also pleased with the company's outlook commentary, which again was ahead of its expectations and has led to the broker upgrading its net profit after tax forecasts by 15% in FY 2023 and 16% in FY 2024.

Pleasingly, its analysts also see potential for this strong earnings growth to continue through to FY 2026. Bell Potter concluded:

We upgrade our rating from Hold to Buy. If A2M can execute on its strategy to achieve ~NZ$2Bn in FY26e revenues and EBITDA margins in the teens, then it would imply compound double digit EPS growth through to FY26e. Exiting the US, transitioning MVM towards nutritionals or execution of buybacks could accelerate this growth trajectory. Recent easing in dairy (notably SMP) and vegetable oil ingredient forward rates also imply the scope for favourable COGS movements in FY24e.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Three ASX shares set to rise up to 47% – Expert

These ASX shares were earnings results winners.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

This ASX 200 gold stock could be a top buy after a 'transformational' year

Bell Potter is bullish on this name. Let's find out why.

Read more »

Woman analysing data.
Broker Notes

What is Bell Potter saying about EOS shares after its results?

The broker remains bullish on this rapidly growing stock.

Read more »

Happy man on a supermarket trolley full of groceries with a woman standing beside him.
Broker Notes

Are Coles shares a buy after its results?

Bell Potter has given its view on the supermarket giant.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares Macquarie says will return 23% to 49%

These shares are well-positioned for a strong year.

Read more »

Woman and man at work looking at data on a tablet at work.
Broker Notes

Buy, hold, sell: Judo Capital, Healius, BHP shares

Morgans has issued new notes on several stocks including BHP, which hit a new record today.

Read more »

Woman with her kitten on a laptop in her home office.
Broker Notes

Buy, hold, sell: Bendigo and Adelaide Bank, PLS, EOS shares

These three ASX shares posted their FY26 results this week. Find out what brokers tip next.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Bell Potter says this ASX biotech could nearly double in value

The US market is starting to open up for this company.

Read more »